Clinical and pathological aspects of filarial lymphedema and its management

Korean Journal of Parasitology

Volumn 46, Issue 3, 2008, Pages 119-125

  Shenoy, R K ^a  

^a TD Medical College Hospital   (India)

Author keywords

Dermato lymphangio adenitis; Elephantiasis; Entry lesions; Limb hygiene; Lymphatic dilatation; Lymphatic filariasis; Lymphedema

Indexed keywords

ALBENDAZOLE; AMOXICILLIN; AMPICILLIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; BENZATHINE PENICILLIN; BENZO[A]PYRENE DERIVATIVE; COTRIMOXAZOLE; DIETHYLCARBAMAZINE; DOXYCYCLINE; FLAVONOID; IVERMECTIN; PARACETAMOL; PENICILLIN G; ANTIFILARIAL AGENT;

ACUTE DERMATOLYMPHANGIOADENITIS; BACTERIAL INFECTION; BRUGIA; CLINICAL FEATURE; COMPRESSION BANDAGE; CONCURRENT INFECTION; DIFFERENTIAL DIAGNOSIS; DOPPLER ECHOGRAPHY; DOSAGE SCHEDULE COMPARISON; ELEPHANTIASIS; ENDEMIC DISEASE; FILARIASIS; FOOT CARE; HEALTH CARE COST; HEALTH PROMOTION; HISTOPATHOLOGY; HOST PARASITE INTERACTION; HUMAN; HYPERTHERMIC THERAPY; INSECT BITE; LIMB DEFORMITY; LIMB SWELLING; LYMPHADENITIS; LYMPHATIC FILARIASIS; LYMPHEDEMA; LYMPHOSCINTIGRAPHY; MYCOSIS; NEMATODE LIFE CYCLE STAGE; PARASITE TRANSMISSION; PATHOGENESIS; PHYSIOTHERAPY; RECOMMENDED DRUG DOSE; SHORT SURVEY; SINGLE DRUG DOSE; WUCHERERIA BANCROFTI; ADULT; ARTICLE; CHILD; PATHOLOGY;

BACTERIA (MICROORGANISMS);

ADULT; CHILD; DIETHYLCARBAMAZINE; ELEPHANTIASIS, FILARIAL; FILARICIDES; HUMANS;

EID: 56149116923     PISSN: 00234001     EISSN: 17380006     Source Type: Journal    
DOI: 10.3347/kjp.2008.46.3.119     Document Type: Short Survey

References (43)

1. World Health Organization. Bridging the Gaps World Health Report. Geneva, Switzerland. WHO. 1995.
2. Michael E, Bundy DAP, Grenfell BT. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 1996; 112: 409-428.
3. Ramaiah KD, Ramu K, Guyatt H, Vijayakumar KN, Pani SP. Direct and indirect costs of acute form of lymphatic filariasis in rural areas in Tamil Nadu, South India. Trop Med Int Hlth 1998; 3: 108-115.
4. Pani SP, Yuvaraj J, Vanamail P, Dhanda V, Michael E, Grenfell BT, Bundy DAP. Episodic adenolymphangitis and lymphedema in patients with bancroftian filariasis. Trans Roy Soc Trop Med Hyg 1995; 89: 72-74.
5. Ramaiah KD, Das PK, Michael E, Guyatt H. Economic burden of lymphatic filariasis in India. Parasitol Today 2000; 16: 251-253.
6. Centers for Disease Control and Prevention, Atlanta, USA. Recommendations of the International Task Force for Disease Eradication. MMWR 1993; 42: 1-38.
7. Ottesen EA. Towards elimination of lymphatic filariasis. In Angelico M, Rocchi G eds, Infectious Diseases and Public Health. Tel Aviv, Israel. Balaban Publishers. 1998, p 58-64.
8. Seim AR, Dreyer G, Addiss DG. Controlling morbidity and interrupting transmission: twin pillars of lymphatic filariasis elimination. Rev Soc Brasil Med Trop 1999; 32: 325-328.
9. Noroes J, Addiss D, Amaral F, Coutinho A, Medeiros Z, Dreyer G. Occurrence of adult Wuchereria bancrofti in the scrotal area of men with microfilaraemia. Trans Roy Soc Trop Med Hyg 1996; 90: 55-56.
10. Dreyer G, Noroes J, Addiss D, Santos A, Medeiros Z, Figueredo-Silva J. Bancroftian filariasis in a paediatric population: a ultrasonographic study. Trans Roy Soc Trop Med Hyg 1999; 93: 633-636.
11. Mand S, Debrah A, Basta L, Adjei O, Hoerauf A. Reliable and frequent detection of adult Wuchereria bancrofti in Ghanian women by ultrasonography. Trop Med Int Hlth 2004; 9: 1111-1114.
12. Fox LM, Furness BW, Haser JK, Brissau JM, Louis-Charles J, Wilson SF, Addiss DG, Lammie PJ, Beach M. Ultrasonographic examination of Haitian children with lymphatic filariasis: a longitudinal assessment in the context of antifilarial drug treatment. Am J Trop Med Hyg 2005; 72: 642-648.
13. Shenoy RK, Suma TK, Kumaraswami V, Padma S, Rahmah N, Abhilash G, Ramesh C. Doppler ultrasonography detects adult worm nests in lymph vessels of children with brugian filariasis. Ann Trop Med Parasitol 2007; 101: 173-180.
14. Freedman DO, de Alemeida Filho PJ, Besh S, Maia e Silva MC, Braga C, Maciel A. Lymphoscintigraphic analysis of lymphatic abnormalities in symptomatic and asymptomatic human filariasis. J Infect Dis 1994; 170: 927-933.
15. Shenoy RK, Suma TK, Kumaraswami V, Rahmah N, Dhananjayan G, Padma S, Abhilash G, Ramesh C. Preliminary findings from a cross-sectional study on lymphatic filariasis in children in an area endemic for Brugia malayi infection. Ann Trop Med Parasitol 2007; 101: 205-213.
16. Gyapong JO, Kumaraswami V, Biswas G, Ottesen EA. Treatment strategies underpinning the global programme to eliminate lymphatic filariasis. Expert Opin Pharmacother 2005; 6: 179-200.
17. Freedman DO, Bui T, de Almeida Filho PJ, Braga C, Maia E, Silva MC, Maciel A, Furtado AE. Lymphoscintigraphic assessment of the effect of diethylcarbamazine treatment on lymphatic damage in human bancroftian filariasis. Am J Trop Med Hyg 1995; 52: 258-261.
18. Shenoy RK, Sandhya K, Suma TK, Kumaraswami V. A Preliminary study of filariasis related acute adenolymphangitis with special reference to precipitating factors and treatment modalities. Southeast Asian J Trop Med Pub Hlth 1995; 26: 301-305.
19. Shenoy RK, Kumaraswami V, Suma TK, Rajan K, Radhakuttyamma G. A double blind placebo controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphedema caused by brugian filariasis. Ann Trop Med Parasitol 1999; 93: 367-377.
20. Suma TK, Shenoy RK, Varghese J, Kuttikkal VV, Kumaraswami V. Estimation of ASO titer as an indicator of streptococcal infection precipitating acute adenolymphangitis in brugian lymphatic filariasis. Southeast Asian J Trop Med Pub Hlth 1997; 28: 826-830.
21. Vincent AL, Urena-Rojas CA, Ayoub EM, Ottesen EA, Harden EG. Filariasis and erisipela in Santo Dominigo. J Parasitol 1998; 84: 557-561.
22. Olszewski WL, Jamal S. Skin bacterial factor in progression of filarial lymphedema. Lymphology 1994; 27: 148-149.
23. Olszewski WL, Jamal S, Manokaran G, Pani S, Kumaraswami V, Kubica U, Lukomska B, Dworczynski A, Swoboda E, Meisel-Mikolajczyk E. Bacteriologic studies of skin, tissue fluid, lymph and lymph nodes in patients with filarial lymphedema. Am J Trop Med Hyg 1997; 57: 7-15.
24. Shenoy RK, Suma T K, Rajan K, Kumaraswami V. Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb. Ann Trop Med Parasitol 1998; 92: 587-594.
25. Weil GJ, Ramzy RM, Chandrashekhar R, Gad AM, Lowrie RC Jr, Faris R. Parasite antigenemia without microfilaremia in bancroftian filariasis. Am J Trop Med Hyg 1996; 55: 333-337.
26. World Health Organization. Lymphatic filariasis: the disease and its control. WHO Tech Rep Ser 1992; no. 821.
27. Kumaraswami V. The clinical manifestations of Lymphatic Filariasis. In: TB Nutman ed, Lymphatic Filariasis. London, U.K. Imperial College Press. 2000, p 103-125.
28. Burri H, Loutan L, Kumaraswami V, Vijayasekaran V. Skin changes in chronic lymphatic filariasis. Trans Roy Soc Trop Med Hyg 1996; 90: 671-674.
29. Ottesen EA. Immunopathology of lymphatic filariasis in man. Springer Semin Immunopathol 1980; 2: 373-385.
30. Partono F. The spectrum of diseases in lymphatic filariasis. Ciba Foundation Sym 1987; 127: 15-31.
31. Dreyer G, Medeiros Z, Netto MJ, Leal NC, Gonzaga de Castro L, Peissens WF. Acute attacks in the extremities of persons living in an area endemic for bancroftian filariasis: differentiation of two syndromes. Trans Roy Soc Trop Med Hyg 1999; 93: 413-417.
32. Panicker KN, Sebasan S. Socioeconomic perspectives. Miscellaneous publications of VCRC. 1990; 16: 42-47.
33. Ramaiah KD, Kumar KN. Effect of lymphatic filariasis on school children. Acta Tropica 2000; 76: 197-199.
34. Witt C, Ottesen EA. Lymphatic filariasis: an infection of childhood. Trop Med Int Hlth 2001; 6: 582-606.
35. Lammie PJ, Reiss MD, Dimock KA, Streit TG, Roberts JM, Eberhard ML. Longitudinal analysis of the development of filarial infection and antifilarial immunity in a cohort of Haitian children. Am J Trop Med Hyg 1998; 59: 217-221.
36. Suma TK. Shenoy RK, Kumaraswami V. Efficacy and sustainability of foot-care programme in preventing acute attacks of adenolymphangitis (ADL) in brugian filariasis. Trop Med Int Hlt 2002; 7: 763-766.
37. Dreyer G, Noroes J, Figueredo-Silva, Piessens WF. Pathogenesis of lymphatic disease in bancroftian filariasis. Parasitol Today 2000; 16: 544-548.
38. Addiss DG, Dreyer G. Treatment of lymphatic filariasis. In Nutman TB ed, Lymphatic Filariasis. London, U.K. Imperial College Press. 2000, p 151-199.
39. Dreyer G, Medeiros Z, Netto MJ, Leal NC, Gonzaga de Castro L, Peissens WF. Acute attacks in the extremities of persons living in an area endemic for bancroftian filariasis: differentiation of two syndromes. Trans Roy Soc Trop Med Hyg 1999; 93: 413-417.
40. Ottesen EA, Duke BOL, Karam M, Bebehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 1997; 75: 491-503.
41. Pani SP, Lall R. Clinical features, pathogenesis and management of lymphatic filariasis. ICMR Bull 1998; 28: 41-51.
42. Jamal S, Pani SP. Filarial lymphedema - Reduction by surgery immediate and late results. Progress in lymphology. XVII - Proceedings of the 17th Int Congr Lymphol, Chennai, India, 19-25 September, 1999, 147-150.
43. Casley-Smith JR. Management of lymphedema in India - A suggested protocol for prevention and treatment. Progress in lymphology. XVII - Proceedings of the 17th Int Congr Lymphol, Chennai, India, 19-25 September, 1999, 151-154.